Block listing six monthly return

RNS Number : 9748L

Orosur Mining Inc

13 July 2026

 

13 July 2026

 

Orosur Mining Inc

("Orosur" or the "Company")

 

Block listing six monthly return

 

London, July 13th 2026. Orosur Mining Inc (TSXV/AIM: OMI), announces the following information in connection with its block listing pursuant to Rule 29 and Schedule Six of the AIM Rules for Companies:

 

Name of Company:		Orosur Mining Inc.
Name of scheme:		Unlisted warrants
Period of return:	From:	14 January 2026	To:	13 July 2026
Balance of unallotted securities under scheme(s) from previous return:		19,752,648 corrected to 19,706,967*
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		nil
Less:  Number of securities issued/allotted under scheme(s) during period:		5,380,898
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		14,326,069

 

Name of contact:	Louis Castro
Telephone number of contact:	07775625724

 

*A discrepancy in the balance of unallotted securities at the end of the last period was identified after the last 6 monthly return, with the correct number being 45,681 securities less than previously disclosed. The correct opening position is 19,706,967 as set out above.

 

For further information visit www.orosur.ca,follow on X @orosurm or contact:

 

 

Orosur Mining Inc.

Louis Castro, Executive Chairman,

Brad George, CEO

[email protected]

Tel: +1 (778) 373-0100

 

SP Angel Corporate Finance LLP - Nomad & Joint Broker

Caroline Rowe / Jen Clarke / Devik Mehta

Tel: +44 (0)20 3470 0470

 

Turner Pope Investments (TPI) Ltd - Joint Broker

Andy Thacker/Guy McDougallTel: +44 (0)20 3657 0050

Flagstaff Strategic and Investor Communications

Tim ThompsonAlison AllfreyFergus Mellon

[email protected]

Tel: +44 (0)207 129 1474

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.